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I. Introduction 
Since the turn of the century, tremendous strides have been made in public health 
practices throughout the world to control death and disability related to communicable 
diseases. The development of vaccines, the introduction of antibiotics, improvements in 
maternal and infant care and improvements in public sanitation, have all served to lower 
mortality rates related to communicable diseases. This trend has been especially true in 
high-income countries, but has also occurred in low to middle income countries. 1 
Coupled with this trend has been the emergence of chronic diseases, or non-
communicable disease, as an increasing threat to the health and well being of the 
developing world. These diseases are characterized by a long latency period, a mixture 
of casual factors including well-known risk factors, a prolonged course of illness, a non-
contagious origin, functional impairment and in curability .10 Cardiovascular disease, 
diabetes, cancer, strokes and chronic pulmonary disease have now become the most 
common causes of death worldwide except in sub-Saharan Africa and the Middle East. If 
this rate continues at its current pace, by the year 2020 non-communicable disease will 
account for 80% of the global burden of disease, causing seven out of ten deaths in 
developing countries. Once thought to be the scourge of the developed, "westernized" 
world, chronic disease is now the largest cause of mortality in the developing world and 
will only continue to escalate unless significant interventions are implemented at both the 
individual and population level. This development is of major significance in low to 
middle income countries because they are ill prepared to respond to this threat through 
either prevention or treatment. They lack the health infrastructure to both provide care 
under the increasing pressure that will be placed on their delivery systems and their 
4 
public health capabilities are not sufficiently developed to implement programs that will 
address the underlying determinants of this growing problem. There will also be 
financial consequences tbat develop as a result of the impact of this illness burden on a 
country's workforce and macroeconomic development. Heart disease, diabetes and 
stroke, for example, are estimated to reduce the gross domestic product by 1 to 5% per 
year in low to middle income countries.3 The combination of lower birth rates and 
increasing life expectancy in developing countries will increase that segment of the 
population that is susceptible to chronic disease. This increases the importance of 
crafting appropriate strategies and programs to respond to this growing problem. This 
paper will present an overview of the extent of the problem, explore the determinants 
behind the rise in non-communicable disease and discuss possible solutions. While there 
will be discussion of the global consequence of this problem, the focus will be on Latin 
American countries. 
II. The Burden of Chronic Disease 
There are three communicable diseases tbat attract a majority of attention from 
international aid agencies: HN/AIDS, tuberculosis and malaria. Data from the World 
Health Organization (WHO) shows that these diseases account for only 12% of the 
deaths in low-income countries and 11% of the Disability Adjusted Life Years (DALY) 
lost. In contrast, cardiovascular disease alone accounts for a 27% mortality rate and 9% 
of DALY lost in low-income countries1. Disability Adjusted Life Years is an approach to 
measure the impact of chronic disease that combines the Years of Life Lost to premature 
death and the Years Lived with Disability to paint a picture of the years lost of a healthy 
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life. Using this method, the burden of adult chronic disease will account for 80% of the 
DALY lost in developed countries and 70% in middle-income nations.7 The WHO's 
statistics show that non-communicable accounts for 60% of the deaths worldwide each 
year and almost half of the global burden of disease. This translates into an estimated 35 
million deaths worldwide in 2005 attributable to chronic disease, which is double the 
number that died from all infectious disease, maternal and prenatal conditions and 
nutritional deficiencies combined.4 These deaths are expected to increase by 17% over 
the next ten years.4 
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This trend is especially alarming in Latin American countries where chronic diseases 
are the leading cause of premature death and disability, accounting for 44% of the deaths 
among men and women below the age of 70 and contributing to almost 50% of the 
DALY lost in the region.4 Cardiovascular disease is a major killer in these countries, 
causing 31% of the deaths and it is predicted that ischemic heart disease and stroke rates 
will nearly triple over the next two decades.4 Cancer deaths have experienced a 33% 
increase since 1990 resulting in 20% of the chronic disease mortality.4 This number is 
only expected to increase. The WHO estimates that 56% of all cancer deaths in 2000 
were in developing countries? Diabetes is on the increase worldwide with estimates of 
366 million cases in 2030, 298 million of whom will live in developing countries. 8 
Chronic respiratory disease is also increasing at an alarming rate in the developing word, 
primarily as a result of smoking. By 2020, chronic obstructive pulmonary disease 
(COPD) is expected to become the third leading cause of mortality across the world.7 
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Cardiovascular disease, diabetes and cancer will be used to discuss and illustrate the 
issues that developing countries face as a result of this chronic disease epidemic. 
Cardiovascular Disease 
Cardiovascular disease is the leading cause of death in developing countries, 
accounting for twice the number of deaths from HIV I AIDS, tuberculosis and malaria 
combined. As was mentioned previously, this is especially true for Latin American 
countries, accounting for a third of all deaths and only expected to increase.4 Developed 
countries are experiencing a decline in age-adjusted death rates for CVD, even though the 
overall disease burden is increasing. This is the result of an aging population that has 
access to prevention and treatment resources allowing people to either delay the onset or 
live longer with their chronic illness. As a result, nearly 80% of the CVD deaths in the 
developed world occur after the age of 60, while this occurs in only 42% of the deaths in 
the developing world.5 This morbidity and mortality is primarily occurring during the 
population's working years, with the resultant decline in a country's productive 
workforce. 
The epidemiological transition as described by Omran in an article from the Millbank 
Quarterly in 1971 defined four stages that countries move through as they progress from 
death due to infectious disease and malnutrition towards deaths due to CVD and other 
chronic illness.24 Stage one is characterized by malnutrition and infectious diseases and 
stage two by improvements in nutrition and sanitation, with the beginning emergence of 
some chronic diseases and hypertension. Stage three represents an increase in chronic 
diseases with greater tobacco use, increased fat and caloric intake that leads to more 
chronic disease deaths than from malnutrition and infectious causes. Stage four occurs 
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when deaths from CVD and cancer predominate, but prevention and treatment avoids 
early deaths and prolongs survival. This transition has been compressed in developing 
countries, resulting in an anticipated 120% increase in CVD for women and 137% 
increase for men between 1990 and 2020. The majority of Latin America falls into stage 
three, with some of the poorer countries falling into stage two where they are still at risk 
for malaria and dengue fever.5 This description is significant in that countries continue to 
face the "double burden" of increasing cardiovascular disease along with the challenges 
posed by communicable disease problems that are still a reality. 
The risk factors that have lead to this epidemic of cardiovascular disease are well 
known. Tobacco use continues to play a major role, as well as increasing rates of obesity 
and lack of appropriate physical activity. These factors also promote the development of 
hypertension, diabetes and hyperlipidemia, all precursors to the development of CVD. 
The consumption of tobacco products and exposure to tobacco smoke is considered to be 
the world's leading causes of preventable death, responsible for about 5 million deaths a 
year, mostly in developing countries including those in Latin America. At least 30% of 
these deaths are from cardiovascular disease.12 It is estimated that 2 million men and 
380,000 women who die from tobacco products are in developing countries. 11 Unless 
appropriate interventions are put in place, the death toll related to cigarettes will continue 
to rise. Tobacco projected deaths are expected to decline in the developed world, but to 
nearly double over the next three decades in the developing world. 12 Globalization of 
tobacco products has made finding a solution especially difficult. Liberalized trade 
policies, global marketing and advertising, sponsorship, direct foreign investment and 
movement of contraband cigarettes have all served to fuel this increase in consumption. 11 
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Hypertension is also an important risk factor for cardiovascular disease and its 
prevalence is growing in low to middle income countries. Mexico has reported an 
increase in the disease from 26% in 1993 to 30% in 2000.4 There is a trend in developing 
countries towards increasing urbanization which is also associated with higher rates of 
hypertension. Urbanization is associated with an increased dependence on motorized 
transportation, more sedentary jobs and less physical activity. There are also dietary 
changes that often involve increased caloric intake from sugars, energy-rich 
carbohydrates, saturate fats and higher sodium intake. The combination of lower levels of 
awareness in the population and less than adequate treatment resources have resulted in 
an increasing morbidity from this condition. Men have a higher prevalence of the disease 
and are less well treated than women. 14 This may also have an impact on the workforce 
as a consequence of increasing cardiovascular mortality. There is some thinking that an 
adverse environment during fetal life and early infancy may predispose an individual to 
risk factors for CVD. This would place the populations of developing countries at higher 
risk due to the previous decades of poorly nourished infants who will now survive into 
adulthood with increased susceptibility to vascular disease. 14 This association between 
low-birth weight infants and later development of chronic disease is a true phenomenon, 
but the explanation may be more genetic than exclusively environmental. 18 As 
developing countries do progress through the epidemiological transition and move 
towards greater "Westernization", the incidence of hypertension will also be expected to 
mcrease. 
This "Westernization" may also be responsible for the increasing prevalence of 
obesity in the developing world, which has tripled in the past 20 years.2 This pattern can 
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be linked to both changes in diet and the level of physical activity. Energy-dense foods 
with higher carbohydrate content are readily available and less expensive. The sugar 
content of the world's food supply is increasing and there has been an increase in the 
consumption of animal-source foods. This trend has also been accompanied by a decrease 
in fresh fruits, vegetables, whole grains and legumes as part of a regular diet. There is an 
increase in the use of motorized transport and energy-saving devices, more sedentary 
employment as the population moves away from agricultural work into service sector 
jobs and less engagement in physical exercise. 15 The availability of video games, 
computers and television certainly contribute to this more sedentary lifestyle. These 
"Western" lifestyle and dietary changes are not completely linked to urban environments, 
but can also be found in the rural environment as well. In Latin American countries 
surveys from 2002 showed that 50 to 60% of adults and 7 to 12% of children were 
overweight or obese.4 This increase in obesity and lack of physical activity is especially 
concerning in children and adolescents, as these patterns of behavior tend to persist into 
adult life. The fact that obesity has such a significant contribution to the disease burden 
in the developing world is directly linked to this association with hypertension, diabetes 
and ultimately cardiovascular disease. 
Diabetes 
This rise in overweight and obesity has led to an epidemic in the prevalence of type II 
diabetes in the developing world. Type II diabetes tends to occur in adulthood, is 
associated with diminished insulin sensitivity and impaired glucose tolerance, and most 
commonly occurs in those who are overweight and sedentary. The WHO predicts that by 
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the year 2025 80% of all the new cases of diabetes will be in the developing world. 
Seven out of ten countries with the highest number of people living with diabetes are in 
the developing world. 16 In Latin American countries, 35 million people are currently 
affected with the disease and this number is expected to double by the year 2025. There 
were close to 300,000 deaths in this region that could be attributed to diabetes in 2003. 
The societal costs were also estimated to approach $65 billion in 2000.4 
The health care infrastructure in developing countries is ill suited to meet the demands 
of this growing epidemic. Low and middle-income countries will account for less than 
15% of the global diabetes spending despite this increase in prevalence of the disease. 
Said another way, more than 80% of the medical care for diabetes occurs in the world's 
wealthiest countries. 19 Those that are in greatest need of care are least able to provide the 
resources or have the ability to pay for it. Direct health care costs related to diabetes 
range from 2.5% to 15% of annual health care budgets in countries that already struggle 
to provide health care to their citizens.20 There is also the indirect cost to the economy of 
decreased worker productivity. 
The cost to individuals and their families is also staggering. Diabetes is a chronic 
condition, requiring long-term medical care and often resulting in long-standing 
morbidity and disability. Most medical care in developing countries is financed with out-
of-pocket spending, often leaving families with the choice of food and shelter over health 
care. The WHO reports that in developing countries, 80% of people will pay directly for 
some or all of their medicines. In Latin America, families will have to pay between 40-
60% of diabetes care costs from their own funds. 16 This creates unique problems for 
patients with chronic illnesses due to their need for long-term medications and ongoing 
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medical care. There is also a lack of access to appropriate health care which can lead to a 
delay in the diagnosis of diabetes with the resultant increase in complications. This is 
especially damaging to those with type I diabetes due to their requirement for insulin, 
which is frequently unavailable. It has been reported that only 3% of patients are treated 
with insulin in the developing world as opposed to 13% in the developed world.16 
Without appropriate treatment using insulin, these patients will suffer premature 
disability and death. 
The medical complications associated with diabetes are also devastating. The 
association with cardiovascular disease has been discussed earlier. Diabetes is 
responsible for over one million amputations a year, at least 5% of worldwide blindness 
and the largest cause of chronic kidney failure. 16 Chronic kidney disease progresses to 
kidney failure, or end-stage renal disease, which requires dialysis treatment or kidney 
transplant. It is estimated that by the year 2030, more than 70% of the patients with end-
stage renal disease (ESRD) will be from developing countries. 17 Diabetes is responsible 
for between 9 to 20% of ESRD in the developing world. In 2003 diabetic kidney disease 
was the most common cause ofESRD in 9 out of 10 Asian countries.2 In China, the 
proportion of cases of ESRD caused by diabetic nephropathy increased from 17% in 
1990 to 30% in 2000? The developing world does not possess the necessary resources to 
care for ESRD patients. There are often insufficient dialysis resources, essential 
medications such as erythropoietin, vitamin D and statins are not readily available and 
patients often have coexisting malnutrition and hepatitis infections. 17 This places an 
incredible burden on families that are already stretched to their limits to care for these 
chronically ill patients. Chronic kidney disease also increases the risk of cardiovascular 
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disease, which is especially important in patients that are most likely suffering from 
diabetes and hypertension. 
Cancer 
Cancer is following the same path as other chronic illnesses in the developing world, 
with major increases in both mortality and incidence. The WHO estimates that the 
cancer death toll could reach 9 million by 2015.20 A large percentage of these deaths will 
occur in the developing world, as evidenced by the nearly 60% that were thought to have 
occurred in 2005.20 This increase is significant in Latin America and the Caribbean 
where there were 479,000 cancer deaths in 2002, a 33% increase from 1990.20 The same 
factors that are responsible for the increase in other non-communicable disease are also at 
play with this increase in cancer diagnosis and death. The population is becoming more 
"Westernized" and there is growing urbanization, both of which are associated with 
increasing tobacco use and changes in dietary habits. By the year 2020, the total number 
of new cases in the developed world is expected to increase by 29%, but in the 
developing world an increase of 73% is forcast. 19 
The "double burden" of disease; the increase in chronic disease while still feeling the 
impact of communicable disease, is also mirrored in the growing cancer incidence. Low 
to middle income countries have a higher rate of cancers that can be attributed to 
infectious diseases in addition to those associated with the developed world. Cervical 
cancer in women, stomach and liver cancer all have etiologies that are linked to 
infectious causes. The public health practices that are necessary to respond to these 
illnesses are woefully lacking in the developing world. There are insufficient funds and 
resources to provide screening when appropriate and treatment options for those newly 
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diagnosed are far below those available in the developed world. This is true for adult as 
well as childhood malignancies. 
Cervical cancer in women serves to illustrate this point well. This is the leading cause 
of death in women in Latin America and the Caribbean, accounting for 37,600 deaths a 
year.20 There is a strong association between certain types of the HPV virus and cervical 
cancer. The developed world has experienced a significant decline in mortality from this 
disease through regular screening of women with pap smears. A new HPV vaccine is 
now available that is given to adolescents before they become sexually active that will 
result in even a greater decline in the incidence of cervical cancer. Developing countries 
are limited in their economic and healthcare infrastructure and are not well equipped to 
offer these services. More that 80% of the new cases of cervical cancer will occur in the 
developing world and will account for up to 250,000 deaths annually.19 Patients often 
have incurable disease when they first present for treatment as a result of the lack of 
access to adequate preventive care. There may also be regional differences in the 
malignant potential for certain HPV viruses. HPV31 and HPV58 virus types are more 
likely to advance to cervical cancer in Latin America and China when compared to the 
. . E 19 expenence m urope. 
Other infectious diseases also add to the cancer burden. Almost 90% of the liver 
cancer burden occurs in the developing world.19 This is primarily due to chronic 
infections with the hepatitis B virus, in spite of the fact that a hepatitis vaccine has been 
available for several decades. Developing countries also have a higher incidence of 
nasopharyngeal cancer and lymphoma that can be attributed to infections with Epstein 
Barr virus. HIV I AIDS patients also have a higher incidence of cancers caused by viruses, 
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such as Kaposi's sarcoma and non-Hodgkin's lymphoma. 19 Add these cancers to cases of 
breast, lung, colon and prostate that are more often seen in the developed world and it is 
no wonder that developing nations are struggling with this problem. 
Just as it does with cardiovascular disease, tobacco use is the single greatest 
environmental threat to the incidence and mortality of cancer in the developing world. 
While the rate of smoking is declining in some industrialized countries, it continues to 
climb in low to middle income countries, particularly in young people and women.19 
The rate of breast cancer is much higher in the developed world, but delayed detection 
and poorer access to effective treatments have resulted in worse outcomes in the 
developing world. Dietary factors are thought to have some bearing on the development 
of colon cancer. As the developing world adopts more of a "western" dietary pattern 
consistent with less fiber, whole grains and fruits, the incidence of colon cancer will 
increase. The overweight and obesity epidemic is expected to also result in an increase in 
pancreatic, endometrial and prostate cancers that are associated with this risk factor. 20 
III. Prevention and Control 
Multiple risk factors and socioecological determinants will require consideration in 
order to address this growing burden of non-communicable disease. While the ultimate 
expression of disease is at the individual level, prevention and control measures must also 
be developed within the context of population management, cultural understanding, 
economic policy and political agendas. The constellation of risk factors that manifest 
themselves as chronic disease, including tobacco use, obesity and decreased physical 
activity, can be traced back to increasing urbanization, globalization and poverty. The 
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response of government and society to these emerging issues will require changes in 
policy, improvements in infrastructure and concerted public education programs in order 
to realize improvements in health. These are challenges that the developing world is ill 
suited to meet and the international community has been slow to acknowledge. 
One of the more significant societal and environmental changes has been the 
migration of populations from rural to urban areas. The lure of employment, improved 
educational opportunities and the possibility of an enhanced lifestyle have helped to 
contribute to this demographic transition. This movement is occuning across the globe 
and is expected to increase. The world population living in urban areas increased from 
36.6% in 1970 to 44.8% in 1994 and is expected to reach 61.1% by 2025.23 This change 
is associated with movement to a more Western environment with the concomitant 
changes in diet and level of physical activity. Diets that are higher in saturated fat, 
sodium content and carbohydrates have been coupled with the decrease in grains, fresh 
fruits and vegetables. These foods tend to be less expensive, are easily available and 
have been marketed more extensively, particularly to the younger population. 
Interestingly enough, this dietary change experienced in the urban environment has also 
had an influence on rural areas as well. Marketing efforts, television, the increased 
availability of processed foods and the desire to appear more "modern" has resulted in 
changing dietary patterns in these areas as well. 23 
Encouraging individuals to make changes in their lifestyle and diet is an important 
component of addressing this problem, but this approach will fall short of achieving 
measurable gains in attacking the underlying problems. Policy changes that regulate or 
provide incentives to food manufacturers to change their products in a healthier direction 
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can be effective.13 Changing the types of fats in food by reducing the trans-fatty acid 
content has been an effective and relatively inexpensive approach. As an example, the 
Netherlands was able to reduce the trans-fat content of the food supply from about 6% of 
the energy content to approximately 1% in a single decade. 13 Legislation could also be 
introduced to decrease the salt content of manufactured food products helping to decrease 
the prevalence of hypertension. 
Education will also be an important component of this population approach. 
Government agencies, such as Ministries of Health, in combination with schools, work 
sites and community groups will be important in delivering the message about adopting a 
healthier diet and lifestyle. The message should also be linked with action plans that 
include offering healthier meals at schools and promoting non-motorized transportation at 
work sites. 13 In developing countries that are stretched for resources, these interventions 
have been shown to be cost-effective according to the Disease Control Priorities Project 
of the WHOY Coronary artery disease events could be reduced by 4% through 
community media campaigns and efforts to replace saturated fats with monounsaturated 
fats in manufactured food products. The total cost is estimated at US$1.80 to US$4.50 
per capita per year depending on the region. The incremental cost-effectiveness ratio 
would range from US$1,865 per DALY averted in South Asia to US$4,012 per DALY 
saved in the Middle East and North Africa. 13 These same assumptions hold true for 
substitution of polyunsaturated fat for trans-fat and for reducing the salt content of foods. 
Urban design and transportation policy initiatives can also have an effect on the level 
of physical activity in the population. The move to urban areas has resulted in more 
sedentary jobs and the reliance on motorized transportation. Enacting policies that 
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discourage automobile use and encourage walking and bicycle transportation can have a 
positive impact. The contrast between Singapore, where policies have been enacted that 
discourage automobile use and promote walking and cycling, and China, where families 
have incentives to purchase automobiles through lower taxes and foreign financing, is 
emblematic of the challenge facing low to middle income countries.13 
The past several decades have seen the development of global markets for goods and 
services that has spread to both developed and developing countries. In the industrialized 
world this has lead to improvements in national income levels, but the same cannot be 
said of the low to middle income countries.22 This failure of globalization to improve the 
national income levels of developing countries has indirectly impacted both their 
government's ability to provide health related resources and the individual's ability to 
access healthcare services. The marketing and production of tobacco and other products 
with adverse impacts on health has also taken on a global approach. 
No other product has benefited to the extent that tobacco has from the globalization of 
the world's economy. It has been said that tobacco is the only consumer product that, 
when used as recommended by its manufacturers, eventually kills half of its regular 
users.
22 No where is this more true than in the developing world. Marketing strategies 
that have been banned in the developed world are allowed to continue in the developing 
world. Young people and women are often the target of these marketing campaigns. 
Policies in developed countries that produce tobacco continue to promote the growing 
and sale of tobacco. The EU spends about 1 billion Euros on agricultural subsidies for 
tobacco and only about 10-20 million Euros on agricultural diversification and tobacco 
control programs.22 Trade agreements between the USA and several Asian countries in 
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the 1980s resulted in an overall increase in tobacco use, especially in poor countries.22 
The availability of illicit tobacco products over the Internet and online marketing efforts 
to promote tobacco products have grown, often with the support of tobacco companies. 
There is variability in the political willingness and capacity to implement the tobacco 
control policies of the World Trade Organization in developing countries. 
Because of its addictive nature, prevention is the best way to control tobacco use. 
Several interventions have been successful in achieving this goal and in reducing tobacco 
consumption. Increasing the tax on tobacco has been one such effective approach, 
especially on lower-income groups and youth. 13 Studies have suggested that the effect of 
raising taxes and increasing the price of tobacco may be twice as high in low to middle 
income countries as in higher income countries. 13 Tobacco use has also been restricted in 
public places causing a reduction in secondhand smoke and creating barriers for current 
smokers. This also serves to stigmatize smokers, making the practice socially 
unacceptable. Public policy that either bans or places strict controls on marketing of 
tobacco products can be combined with public awareness campaigns to highlight the 
dangers of smoking and encourage quitting. The adverse health effects of smoking are 
still not widely known and accepted in the developing world. 13 It has also been shown 
that efforts to reduce the demand for tobacco are cost effective. A 70% increase in the 
price of tobacco could avert 10 to 26% of all smoking related deaths worldwide, 
especially in low to middle income countries. 13 In low to middle income countries, a 
33% price increase translates to a cost-effective ratio of US$3 to US$42 per DALY 
averted.13 Despite its usefulness, this approach to tobacco control has been underutilized. 
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Considering adjustments for purchasing power, the cost of tobacco products actually fell 
in most developing countries from 1990 to 2000. 13 
Prevention and control efforts are dependent on an adequate healthcare deli very 
system and an appropriate public health infrastructure to provide effective interventions 
and surveillance activities. Developing countries will continue to experience the "double 
burden" of responding to both the continued communicable disease burden and the 
increasing prevalence of chronic disease. The approach to chronic disease entails 
responding to multiple problems over an individual's lifetime and requires an integrated 
approach the cuts across multiple medical specialties, patients, families and the 
community. Typically, those individuals who are at the greatest risk for contracting 
disease and experiencing significant morbidity and mortality receive the most attention 
from the healthcare system. Patients with diabetes and hypertension, for example, 
consume a large part of the healthcare dollar. On the contrary, risk factors are widely 
distributed throughout the population and addressing these will require a different 
approach. The greatest impact will come from prevention and control of these risk 
factors, requiring collaboration across multiple sectors of society in these low to middle 
income countries. The capacity of developing nations to respond to non-communicable 
disease prevention is weak and their ability to increase capacity is limited.Z2 Health care 
spending by developing countries as a percentage of their gross domestic product is half 
that spent on health care in developed countries. Low to middle income countries spend 
about $74 per capita on health care, compared with $2,700 in high-income countries.5 
Most health systems in these countries continue to focus on treatment rather than 
prevention and control. Even when there are effective treatments available, the ability to 
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implement them is limited. An adequate healthcare workforce is lacking and access to 
health services is limited by one's ability to purchase those services. As an example, 
lower cost options do exist in the area of secondary prevention of cardiovascular disease, 
but they are underutilized. The generic, multi -drug regimen of an aspirin, a statin for 
cholesterol management, metoprolol, a beta blocker for its cardia-protective effects, and 
Iisinopril, an ACE inhibitor for hypertension control, has been shown to effectively 
reduce the morbidity of CVD.5 The combination could produce a cost-effectiveness ratio 
of US$310 to US$390 per QALY gained, but only 10 to 20% of those who would 
potentially benefit are given these medications.5 Cancer is another area where diagnosis 
and treatment are often delayed as a result of poor resources. Patients do not often seek 
treatment until their disease is far advanced and incurable. In developed countries, 80% 
of patients with cancer of the breast, cervix and mouth are diagnosed at an early stage, 
whereas in developing countries the figure is only 20%.21 This lack of early detection 
and prevention is largely responsible for the disparity in mortality experienced by the 
developing world, an almost 5-fold increase in death rates. 19 
The response of governing and policy making bodies from around the world to the 
non-communicable disease epidemic has paled in comparison to the resources committed 
to communicable disease. Heads of state who attended the 08 summit in 2000 
acknowledged that health is a "key to prosperity" and that poor health is associated with 
poverty, but they failed to commit resources to chronic disease, establishing a Global 
Fund for HIV I AIDS instead. 8 Heads of state have been reluctant to approve global 
strategies to control tobacco and reduce sugar consumption for fear of the impact on their 
farmers. The WHO performed an assessment of the Ministries of Health of 185 countries 
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from around the world and found a high level of awareness about chronic disease, but 
there was a decided lack of follow through. Only 33% of countries had budget lines for 
chronic disease, while most countries lacked comprehensive policies and an integrated 
approach to prevention and surveillance.8 The WHO has begun to pay increasing 
attention to chronic disease care, both as a global entity and through its regional offices. 
The global strategy on "Prevention and Control of Non-communicable Disease" was 
published in 2000 and a subsequent report on "Diet, Physical Activity and Health" was 
released in 2002-2004. The landmark resolution on the "Framework Convention on 
Tobacco Control" was accomplished in 2003. This was the first time the WHO had used 
its treaty-making right to address a global public health threat. 8 A report from the WHO 
Secretariat given to the 120'h session of their Executive Board published in January of 
2007 outlined a global strategy for prevention and control of non-communicable 
diseases.3 In spite of that attention, the resources committed to chronic disease by the 
WHO are small. The WHO spends only $0.50 on chronic disease (all non-communicable 
disease except mental health) per death per person compared with $7.50 for leading 
communicable diseases.8 
Academic institutions and schools of public health in the United States are 
instrumental in training large numbers of public health officials from developing 
countries and yet a review of their curriculum shows a lack of focus on chronic disease in 
their international health programs. 8 Research support also continues to focus on 
infectious disease, although there has been some effort to increase funding for chronic 
disease study. The Fogarty International Center, the international component of the U.S. 
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National Institute of Health, now allocates one third of its resources to chronic disease 
research and training in the developing world.8 
Aid agencies and donors continue to commit the majority of their funding to 
communicable disease support. Funding agencies view infectious diseases as treatable 
with medications and vaccines and as possessing a time course that can have funding 
limits. Chronic diseases, on the other hand, are life-long problems with multiple 
determinants. Official Overseas Development Aid to the health sector contributed $2.9 
billion in 2002, with only 0.1% allocated to chronic disease. The true figure may be 
higher since about 30% of Overseas Development Aid goes to basic health services, of 
which a proportion would benefit chronic disease programs, but the total still falls short 
of what is required. 8 There has been some support for tobacco control from the UN 
foundation and the Rockefeller Foundation, but the Bill and Melinda Gates foundation 
does not include chronic disease care in its portfolio.8 
The World Bank and numerous nongovernmental agencies (NGOs) play a role in 
assisting developing countries to address problems of poverty, education, health and 
infrastructure development. These organizations have been slow to focus attention on the 
problem of chronic diseases in low to middle income countries. In the five years leading 
up to 2004, the World Bank provided $4.25 billion in loans to countries for health sector 
work, about 2.5% of which was allocated to "non-communicable disease prevention and 
control", all in Eastern Europe.8 The Asian Bank is the only Regional Development 
Bank that includes policies on chronic diseases, but it has been associated with few 
spending commitments. 8 The focus has continued to center on communicable diseases 
while maintaining that individuals are responsible for the prevention and treatment of 
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chronic disease and this is a function of private markets. NGOs did contribute work to 
the development of the WHO's Framework Convention for Tobacco Control, but overall 
their response to attacking the chronic disease problem has been lacking. 
The United Nation's Millennium Development Goals are eight goals that have been 
agreed upon by all the world's countries with a target date of 2015.24 Goal number 6 
proposes to attack "IllY/AIDS, malaria and other diseases", but there is no mention of 
non-communicable disease in this statement. The 2006 report publishes achievements in 
the fight against IllY/AIDS and malaria, but does not address the problems from CVD, 
diabetes, strokes and cancer that kill a much greater number of people. Other UN 
initiatives such as the Population Fund and the Children's Fund also fail to include 
programs targeted at risk factors for prevention and control of chronic diseases. 8 
There are several persistent misconceptions about chronic disease that may also 
hamper policy makers when developing prevention and control programs. When viewed 
from the perspective of the developed world, chronic diseases seem to afflict only the 
affluent and the elderly. While it is true that chronic disease can develop as a country 
becomes more "Westernized", the experience in the developing world is that these are 
often problems of the country's most poor residents who have high rates of obesity and 
tobacco use. Cardiovascular disease affects a much higher proportion of adults during 
their working years, especially the male population. Chronic disease is also thought to 
constitute a problem that individuals are responsible for developing as a consequence of 
their behavior. The same could be said of certain communicable diseases and it is a 
belief that ignores the role public policy plays in regulating the environment and the 
marketplace, for example with tobacco and urban planning. Resources are scarce in 
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developing countries and there is the belief that these resources should be focused on 
controlling communicable diseases before approaching chronic illness prevention. This 
approach may not be valid in that certain infectious diseases can cause cancer; tobacco 
use increases mortality from tuberculosis, and antiretroviral therapy in HIV -infected 
persons increases the risk of CVD. 8 Chronic disease programs need to be in place along 
side those dedicated to infectious disease. Tobacco control programs will have an impact 
here as well as programs to provide vaccination against HPV infections that are linked 
with cervical cancer. Chronic disease control programs are not overly expensive and 
interventions can be implemented with proven, cost-effective strategies. 
N. Conclusion 
Chronic diseases are the greatest cause of morbidity in the world and nowhere is this 
truer than in the developing world. This trend is expected to only increase over the next 
several decades with little hope for improvement. Developing countries are experiencing 
the epidemiological transition of movement away from morbidity and mortality strictly 
confined to malnutrition and infectious disease pandemics towards death and disability 
related to chronic illnesses. This transition is far from complete though, leaving these 
countries still facing the "double burden" of responding to communicable and non-
communicable diseases. Increasing pressure from urbanization, poverty, globalization 
and poor literacy will continue to burden the governmental systems, social agencies and 
healthcare systems in the developed world. The development of multiple risk factors 
such as tobacco use, obesity, poor diets and lack of physical activity, will continue to lead 
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to an increasing prevalence of cardiovascular disease and diabetes with a subsequent 
negative impact on the workforce. 
The effort to address this global problem will require action on three broad fronts. 
First, non-communicable disease must occupy a significant place on the agenda of 
organizations such as the WHO, the United Nations, the World Bank and other NGO's. 
While the WHO has been a leader in this area, appropriate strategies and funding must be 
developed and promoted by all these agencies. They will need to collect and provide 
accurate data about the impact of this problem on the world's health and economy. 
Second, governments in these low to middle income countries will need to develop and 
implement policies that address the determinants of chronic disease risk factors. This 
would include tobacco control and food product legislation along with transportation 
plans that will encourage alternatives to automobile use. Global companies will have to 
be held accountable for their marketing practices that promote unhealthy behaviors. 
Funding will be needed for educational programs directed at healthy lifestyles and diet. 
This should happen in schools, workplaces arid in the public sector. These governments 
will also be in a position to negotiate for access to inexpensive therapies for treatment. 
Third, the healthcare workforce will need increased development and training. 
Prevention and control of chronic illness requires a strong primary care workforce. The 
approach to chronic illness care is different from medical care needed for acute illness. 
Evidence-based approaches to chronic illness care will require dissemination and 
implementation in the provider community. Countries will need a strong public health 
system that is responsible for ongoing surveillance activities and increased health 
promotion. This will require integration and collaboration between patients, their 
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families, the community and the healthcare providers. Countries will need aid and 
support to develop strategies that allow economic growth in the setting of preserving the 
ability of all citizens to lead healthy lives and preserve a legacy of health for future 
generations. Unless we strengthen our efforts to address this growing epidemic, the 
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